JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...

Novel analytical methodologies, real-world data (RWD), innovative trial designs, and new technologies are crucial to optimise ...

Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...

Lilly reckons that the new plants will employ around 3,000 workers, including engineers, scientists, operations personnel, ...

I envision Chiesi as a proactive leader driving innovation and collaboration within the rare disease community. Our goal is ...

US District Judge William Alsup's restraining order has been granted on the grounds that the Office of Personnel Management ...

"Many loss of pulse incidents happen when the person is alone, leaving them with effectively no chance of receiving ...

For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...

Eikon Therapeutics has added to its already copious cash reserves with a $351 million fourth-round financing to fund a ...

Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic ...